The latest health stories from the Canadian Light Source synchrotron
Researchers from University of Saskatchewan, University of Southern Denmark discover tissue regrowth in trabecular bone, which makes up 20% of skeleton.
UGuelph team recreates cannabistilbene, a group of molecules thought to offer relief from acute and chronic inflammation
"Molecular glue" could be used to control activity of harmful proteins
University of Guelph researchers say findings raise questions about risks to human health posed by waste material
Canadian, American researchers identify promising target for medication to fight Streptococcus pneumoniae
International research team used CLS to map structure of human antibodies bound to their prototype vaccine.
UVic researchers use synchrotron light to develop more sensitive detector for next-generation CT scanners
Synchrotron X-rays show particles far tinier than previously shown and in concentrations exceeding levels set by human health agencies
Identifying 3D structure of enzymes by University of Guelph researchers key first step in harnessing alterations for disease treatments.
McGill researchers find two enzymes that don't use target mimicry to attack antibiotics
Researchers from Queen's University discover protein's body looks "more like a folded camp chair than a long, flexible pole."
Model developed by USask researchers at VIDO, College of Engineering shows promise for improving study of tuberculosis, cystic fibrosis
Researchers at SickKids / University of Toronto show curvature, stiffness in fish spine predictive of scoliosis
Researchers from University of Windsor combine collagen, semiconducting polymers to create flexible material that matches performance of current gen organic electronics
By adding small amount of material to anode, McGill researchers increased energy density by 20%
Researchers from Queen's University identify promising approach to prevent bacteria from binding to cells
First-of-its-kind structural data about protein family is key for drug discovery
Researchers from Western University find smallest nanoparticles tend to perform best.
Quebec researchers discover weak spot in Ras protein that may be ideal target for molecular drug treatment.
University of Guelph researchers use synchrotron light to develop two new approaches that better mimic real meat.
Material made from natural ingredients generates electricity when squeezed.
International research team uses CMCF beamline to study treatments targeting P. vivax parasite
McGill researchers "crack the code" on how molecular machinery inside microbes builds antibiotics
USask research suggests imaging technique currently available only at synchrotrons could one day be used in clinical setting
UBC researchers deepen our understanding of how bacterium breaks down dietary fibre
Research by McGill's Kalle Gehring lab could pave way for new treatments for this incurable, degenerative disease
Unique glue made of mineral that oyster arranges so it's soft on outside, progressively harder on inside
McGill researchers use synchrotron to determine mechanics, structure of bones in Marfan syndrome
Research could lead to cancer vaccines and drought-resistant crops
Scientists at Quebec's National Institute of Scientific Research (INRS) discover how to modify function of common enzymes.
USask researchers use synchrotron light to study emerging, green technology for decontaminating eggs
Breakthrough by researchers at UBC, McMaster paves way for new drugs to treat infections resistant to traditional antibiotics
Researchers from Quebec's National Institute of Scientific Research (INRS) solve structure of protein that plays a key role in helping H. pylori bind to stomach lining
Researchers from Western University use CLS to obtain highly detailed images of the inner ear, paving way for customized programming strategies for hearing implants
Researchers from University of Manitoba, Leiden University Medical Centre (Netherlands) gain new insights into porcine reproductive and respiratory syndrome virus (PRRSV), which costs Canadian pork industry estimated $130M annually.
University of Alberta research could pave way for immunocompromised people to safely treat infection.
Using CMCF beamline, researchers from Hospital for Sick Children decode how human antibodies protect us against malaria
New antimicrobial coating could revolutionize cleaning methods
USask researchers have developed a better membrane for dialysis machines that could lead to safer treatment, improved quality of life for patients with kidney failure.
Researchers from the University of British Columbia (UBC) have identified a new protein that helps an oral bacterium thrive in other locations around the body.
Scientists from the University of Guelph have used the Canadian Light Source (CLS) at the University of Saskatchewan to better understand how several infectious bacteria, including E. coli., build a protective sugar-based barrier that helps cloak their cells.
Researchers from McGill University have made an exciting discovery about specific proteins involved in the spread of certain cancers.
A research team based in Winnipeg is using the Canadian Light Source (CLS) at the University of Saskatchewan to find new, cutting-edge ways to battle cancer.
Researchers used the CLS to uncover how structures in cannabis flowers are connected to the plant's complex chemistry.
Researchers from the University of Toronto (U of T) are harnessing the power of proteins to stop cancer cells in their tracks.
Researchers from the University of Toronto (U of T) and The Hospital for Sick Children (SickKids) have identified a promising therapeutic target to help treat lung infections in cystic fibrosis (CF) patients.
Application of a discovery that was aided in part by the Canadian Light Source (CLS) at the University of Saskatchewan has advanced to pre-clinical trials and is now the basis of a dynamic new startup.
Osteoporosis takes heavy toll on Canadians in terms of physical suffering and economic burden.
Wilfrid Laurier researchers are exploring how bacteria target weak points in the connective ligaments in your mouth.
Fresh water is a finite resource vulnerable to contamination.
Although the COVID-19 pandemic may feel like it is winding down for many people, there is still much to be learned about the virus that could help us to keep it at bay in the future.
Strokes are the third leading cause of death in Canada and have impacted close to 880,000 Canadians over the age of 20.
Developing therapeutics for COVID-19 should lessen the length and severity of the illness, keeping more people out of the hospital and improving patient outcomes.
New glow-in-the-dark material can track path of drugs through the human body
For the first time, researchers have used synchrotron imaging to study both the size and spread of bullet fragments in big game shot by hunters.
New structural information about an enzyme target in cancer medicine could help the development of next generation inhibitors.
Tiny motors play large roles in our cells and are targets for new therapies.
Using light brighter than the sun to help identify the cause of hip implant failure.
Synchrotron’s “superhuman vision” made it easy to detect markers of brain damage.
About 38 million people globally are living with HIV.
Scientists work to unlock the full potential of biological machines that can have a huge impact on human health.
Using the CLS, McGill researchers have discovered a small molecule that may help combat COVID-19 and could contribute to a new arsenal of treatments slowly making their way to market.
Researchers analyze chemicals that present health concerns as materials degrade.
Scientists are looking to harness the immune system to fight cancer.
McGill University researchers used the CLS to advance a novel method for growing synthetic bone tissue.
Dr. Kendra Furber uses Mid-IR to focus in on specialized brain cells
A. baumannii is a WHO-recognized critical priority pathogen for research, due to antibiotic resistance
One in every ten Canadians has kidney disease, according to the Kidney Foundation.
Heart valve calcification is one of the leading causes of death in Canada.
Pain relief is a critical issue in medicine, but effective pain management is often overlooked.
Scientists are designing better versions of the drugs used to fight antimicrobial-resistant germs like the deadly hospital-acquired superbug MRSA.
Researchers used the CLS to identify a potential bone health therapy.
Important molecular insights for designing improved cancer therapies.
Filtering out pollutants from indoor air is very important for the health of Canadians - as we spend up to 90% of our time indoors.
Researchers with USask Engineering were able to view an industrial milk-filtering #membrane in a way not seen before using our BMIT beamline
Researchers from the University of Toronto have developed antibodies that can neutralize COVID-19.
Using the CLS, researchers have isolated some promising inhibitors that could be used to treat COVID-19 infections.
Cradle-to-grave product development of successful detergent for athletic use.
Determination of the chemical differences between inorganic salt-based nutritional supplements and amino acid chelate products.
Researchers from McGill University used the CLS to determine the physical structure of largest complex ever measured using the CMCF beamline.
A team of international collaborators has been researching a promising new therapeutic for the treatment of strokes and other brain injuries.
Over 100,000 Canadians are living with Parkinson’s disease. McGill researchers are using the Canadian Light Source to help search for potential drug targets for the disease.
Dr. Jake Pushie is using the CLS and VIDO to study the virus that causes COVID-19 and its effects on blood vessels.
Researchers report new insights into how a class of antibiotics commonly used in both medicine and agriculture are rendered useless by resistant germs.
University of Guelph scientists fight antibiotic resistance by using our synchrotron to study scab disease in potatoes.
University of Saskatchewan scientists have designed an air sanitizing device that could help protect us from airborne pathogens like the ones that cause COVID-19 and the common flu.
Dr. Dustin King with Simon Fraser University and colleagues are using our CMCF beamlines to get a better understanding of how CO2 could be controlled to improve our immunity.
Dr. Jake Pushie's team at the University of Saskatchewan is examining risk factors for bleeding in the brain after stroke.
Ecologik, a Saskatoon-based company, used our CMCF beamline to analyze their dishwasher detergent to ensure there were no unknown contaminants in their product.
McGill researchers used the CLS to get one step closer to understanding the origins of arterial calcification, a process that contributes to heart disease.
By deepening our understanding of how Tuberculosis bacteria feed themselves, University of Guelph researchers have identified a potential target for drug treatment.
Researchers are working to better understand how decontamination procedures might affect the structure and potential reuse of N95 masks.
A team of researchers from the CLS and Memorial University set out to determine whether bromine could be found in household dust.
Streptavidin and biotin form a strong bond invaluable for many biotechnological applications. Researchers have taken a new approach to improve these widely used biotechnology tools.
A University of Nevada researcher is using our Mid-IR beamline to study how nucleic acids get damaged under X-ray irradiation.
Researchers from the CLS and Université Laval are trying to create a device that would make healthcare testing more efficient
